NO135248B - - Google Patents
Download PDFInfo
- Publication number
- NO135248B NO135248B NO4318/71A NO431871A NO135248B NO 135248 B NO135248 B NO 135248B NO 4318/71 A NO4318/71 A NO 4318/71A NO 431871 A NO431871 A NO 431871A NO 135248 B NO135248 B NO 135248B
- Authority
- NO
- Norway
- Prior art keywords
- fluoro
- hydroxybenzyl
- piperidino
- salt
- butyrophenone
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9349570A | 1970-11-27 | 1970-11-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO135248B true NO135248B (is") | 1976-11-29 |
NO135248C NO135248C (is") | 1977-03-09 |
Family
ID=22239276
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO4318/71A NO135248C (is") | 1970-11-27 | 1971-11-24 |
Country Status (16)
Country | Link |
---|---|
JP (1) | JPS5623985B2 (is") |
BE (1) | BE775593A (is") |
CA (1) | CA957376A (is") |
CH (1) | CH562215A5 (is") |
DE (1) | DE2158136C2 (is") |
DK (1) | DK135895B (is") |
ES (1) | ES397370A1 (is") |
FR (1) | FR2115451B1 (is") |
GB (1) | GB1314955A (is") |
IE (1) | IE35778B1 (is") |
IL (1) | IL38079A (is") |
NL (1) | NL175411C (is") |
NO (1) | NO135248C (is") |
PH (1) | PH9306A (is") |
SE (1) | SE369900B (is") |
ZA (1) | ZA717147B (is") |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE7409245L (is") * | 1973-07-19 | 1975-01-20 | Robins Co Inc A H | |
US4246268A (en) * | 1979-02-09 | 1981-01-20 | Richardson-Merrell Inc. | Neuroleptic-4-(naphthylmethyl)piperidine derivatives |
IE49998B1 (en) * | 1979-08-06 | 1986-01-22 | Merrell Dow Pharma | 4-(naphthalenyloxy)piperidine derivatives |
US4283404A (en) * | 1979-09-04 | 1981-08-11 | Richardson-Merrell Inc. | Aroylethenylpiperidinobutyrophenone antipsychotic agents |
US4284636A (en) * | 1979-09-04 | 1981-08-18 | Richardson-Merrell Inc. | Cinnamoylpiperidinobutyrophenone antipsychotic agents |
ZA806501B (en) * | 1979-10-27 | 1981-10-28 | Richardson Merrell Inc | 4-(4-alkyl-aroyl-1-piperidino)butyrophenone antipsychotic agents |
US4783471A (en) * | 1985-07-02 | 1988-11-08 | Merrell Dow Pharmaceuticals Inc. | N-aralkyl piperidine methanol derivatives and the uses thereof |
ZA864772B (en) * | 1985-07-02 | 1987-02-25 | Merrell Dow Pharma | Novel chemical compounds |
IL117149A0 (en) * | 1995-02-23 | 1996-06-18 | Schering Corp | Muscarinic antagonists |
AR052977A1 (es) * | 2004-09-13 | 2007-04-18 | Fmc Corp | Procesos para preparar n-(arilmetil sustituido)-4-(metil disustituido)piperidinas e intermediarios |
-
1971
- 1971-10-26 ZA ZA717147A patent/ZA717147B/xx unknown
- 1971-10-27 GB GB4994271A patent/GB1314955A/en not_active Expired
- 1971-10-27 IE IE1361/71A patent/IE35778B1/xx unknown
- 1971-10-29 CA CA126,448A patent/CA957376A/en not_active Expired
- 1971-11-04 IL IL38079A patent/IL38079A/xx unknown
- 1971-11-16 PH PH13014*UA patent/PH9306A/en unknown
- 1971-11-17 CH CH1670071A patent/CH562215A5/xx not_active IP Right Cessation
- 1971-11-18 JP JP9200371A patent/JPS5623985B2/ja not_active Expired
- 1971-11-19 BE BE775593A patent/BE775593A/xx not_active IP Right Cessation
- 1971-11-24 DE DE2158136A patent/DE2158136C2/de not_active Expired
- 1971-11-24 SE SE15032/71A patent/SE369900B/xx unknown
- 1971-11-24 NO NO4318/71A patent/NO135248C/no unknown
- 1971-11-25 NL NLAANVRAGE7116194,A patent/NL175411C/xx not_active IP Right Cessation
- 1971-11-26 ES ES397370A patent/ES397370A1/es not_active Expired
- 1971-11-26 FR FR7142529A patent/FR2115451B1/fr not_active Expired
- 1971-11-26 DK DK582171AA patent/DK135895B/da not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
PH9306A (en) | 1975-08-18 |
IL38079A (en) | 1974-10-22 |
NL175411B (nl) | 1984-06-01 |
DE2158136A1 (de) | 1972-05-31 |
FR2115451A1 (is") | 1972-07-07 |
NL7116194A (is") | 1972-05-30 |
NL175411C (nl) | 1984-11-01 |
IL38079A0 (en) | 1972-01-27 |
BE775593A (fr) | 1972-03-16 |
NO135248C (is") | 1977-03-09 |
ZA717147B (en) | 1972-07-26 |
IE35778B1 (en) | 1976-05-26 |
ES397370A1 (es) | 1974-05-16 |
GB1314955A (en) | 1973-04-26 |
DK135895B (da) | 1977-07-11 |
CA957376A (en) | 1974-11-05 |
DK135895C (is") | 1977-12-12 |
CH562215A5 (is") | 1975-05-30 |
SE369900B (is") | 1974-09-23 |
DE2158136C2 (de) | 1982-11-18 |
FR2115451B1 (is") | 1975-02-07 |
JPS5623985B2 (is") | 1981-06-03 |
IE35778L (en) | 1972-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US2914563A (en) | Therapeutic composition | |
US3014911A (en) | Derivatives of dibenzo[a, e]cycloheptatriene | |
US4072686A (en) | 1-(3,3,3-Triarylalkyl)-4-phenyl-piperidinealkanols | |
US4069223A (en) | 4-Aminomethyl-1-(3,3,3-triarylpropyl)-4-arylpiperidine and derivatives thereof | |
NO148150B (no) | Analogifremstilling av terapeutisk aktive piperazinderivater | |
HU193161B (en) | Process for preparing new n-alkyl-norscopines | |
NO155490B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktivt 4-)1"-hydroksy-2"-(n-imidazolyl)etyl)bibenzyl. | |
NO135248B (is") | ||
NO750395L (is") | ||
CA1120036A (en) | 4-(naphthylmethyl)piperidine derivatives | |
RO121382B1 (ro) | Procedeu şi intermediari pentru prepararea 1-benzil-4-[(5,6-dimetoxi-1-indanon)-2-il-]metilpiperidinei | |
SE451328B (sv) | 2-substituerade bensofuranderivat, forfarande for deras framstellning samt farmaceutiska kompositioner innehallande nemnda derivat | |
US3852455A (en) | 4-{8 4({60 hydroxybenzyl)piperidino{9 -4-fluorobutyrophenone derivatives as tranquilizers | |
US2759935A (en) | Substituted 3-phenyloxindoles | |
NO742621L (is") | ||
NO793473L (no) | Fremgangsmaate til fremstilling av terapeutisk virksomme fenylalkylaminer | |
NO753672L (is") | ||
US4024264A (en) | Diphenylbutylpiperidines | |
NO131173B (is") | ||
CA1123440A (en) | 4-(naphthalenyloxy)piperidine derivatives | |
SU895291A3 (ru) | Способ получени производных 4-амино-2-пиперидинохиназолина или их солей с фармацевтически приемлимыми кислотами | |
US3888867A (en) | 4-(4-(alpha-hydroxybenzyl)piperidino)4'-fluorobutyrophenone derivatives | |
DK153843B (da) | Analogifremgangsmaade til fremstilling af 5-substituerede 10,11-dihydro-5h-dibenzooea,daacyclohepten-5,10-iminer eller salte deraf | |
HU194846B (en) | Process for the production of derivatives of piperidine | |
US3117976A (en) | Nu-alkyl-pyrrolidine-2-methanol, alpha cyclohexyl mandelates |